TGA to review advertising of stem cell therapies to the Australian public
Published
Related content
-
Direction about advertisements: Mr David Leyonhjelm
Mr Leyonhjelm was directed to cease advertising a prescription medicine for the treatment of Covid-19. -
Canberra individual fined $2,664 for alleged unlawful advertising of a homoeopathic medicine in relation to COVID-19
The TGA has issued an infringement notice for $2,664 to an individual from Canberra, for a breach of the Therapeutic Goods Act 1989 in relation to the alleged unlawful advertising of a homoeopathic medicine with COVID-19 claims. -
Stem cell treatments and regulation - a quick guide for consumers
Commonly asked questions about stem cells and regulation